Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Lobectomy is the standard of care for early-stage non-small-cell lung cancer (NSCLC). The survival and clinical benefits of segmentectomy have not been investigated in a randomised trial setting. We aimed to investigate if segmentectomy was non-inferior to lobectomy in patients with small-sized peri...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 399; no. 10335; pp. 1607 - 1617
Main Authors:	Saji, Hisashi, Okada, Morihito, Tsuboi, Masahiro, Nakajima, Ryu, Suzuki, Kenji, Aokage, Keiju, Aoki, Tadashi, Okami, Jiro, Yoshino, Ichiro, Ito, Hiroyuki, Okumura, Norihito, Yamaguchi, Masafumi, Ikeda, Norihiko, Wakabayashi, Masashi, Nakamura, Kenichi, Fukuda, Haruhiko, Nakamura, Shinichiro, Mitsudomi, Tetsuya, Watanabe, Shun-Ichi, Asamura, Hisao
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 23.04.2022 Elsevier Limited
Subjects:	Carcinoma, Non-Small-Cell Lung Clinical trials Complications Disease Fatalities Humans Lung cancer Lung Neoplasms Lymphatic system Mastectomy, Segmental Medical prognosis Metastasis Neoplasm Recurrence, Local - pathology Neoplasm Staging Non-small cell lung carcinoma Oncology Ostomy Patients Pneumonectomy Postoperative Randomization Registration Regression models Respiratory function Small cell lung carcinoma Staples Subgroups Surgery Survival Tumors Japan
ISSN:	0140-6736, 1474-547X, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!